ARK Raises Its CRISPR Therapeutics Stake to 10.69%

ARK Investment Management is making waves with its latest move.

In a recent 13G filing, Cathie Wood and her team increased their stake in CRISPR Therapeutics AG $CRSP from 8.78% to 10.69%.

This move makes CRSP the fifth largest holding in ARK’s portfolio, highlighting their strong belief in the company and its groundbreaking work in gene editing.

Every time ARK Investment Management makes a move, it’s worth paying attention – and their latest activity is no exception.

Here’s The Hot Corner, with data from December 10, 2024:

Adding to the activity, GIC Private Ltd., Singapore's sovereign wealth fund, disclosed an initial 5.66% stake in Paymentus Holdings $PAY in a schedule 13G.

Last but not least, we witnessed insider activity in PBF Energy $PBF, Matador Resources Company $MTDR and Biglari Holdings Inc $BH.